By David Tuller, DrPH Two weeks ago, I exchanged e-mails with Professor Roger Jones, editor of the British Journal of General Practice. I asked him to correct a false statement in an editorial about the cost of so-called medically unexplained symptoms to the National Health Service. In response, he invited me to send in “one …
Trial By Error: My Follow-Up Letter to the British Journal of General Practice Read More »
By David Tuller, DrPH On Wednesday, I sent the following to Dr Fiona Godlee, editorial director of BMJ. The topic, once again, was the ethically and methodologically challenged Lightning Process study, which was published two years ago in Archives of Disease in Childhood, a BMJ journal. My letter was prompted by the recent appearance of …
Trial By Error: A Plea to Fiona Godlee on a Familiar Topic Read More »
By David Tuller, DrPH Reuters reporter Kate Kelland informed me in January that my habit of routinely sending open letters to researchers and journals to expose what I consider to be bogus studies was “harassment,” according to those who perceive themselves as my victims. Whatever. I disagree that writing lots of letters about violations of …
Trial By Error: My Letter about MUS to the British Journal of General Practice Read More »
By David Tuller, DrPH Earlier this month, as I have reported, I sent a letter to the Reuters global editor for “ethics and standards” about my concerns relating to last month’s hit piece on ME/CFS patients and me. (I put those words in quotation marks because I have seen little in the reporting and publication …
By David Tuller, DrPH Today I sent the following e-mail to Sue Paterson, director of legal services at Bristol University. I cc-d several other people on the e-mail. ********** Dear Ms Paterson, Earlier this month, I sent you an e-mail to ask, among other questions, when Bristol University plans to finish its investigation of studies …
Trial By Error: My Latest Letter to Bristol’s Legal Department Read More »
By David Tuller, DrPH I’ve never spoken to Francis Collins, who heads the National Institutes of Health. He comes across as a decent, caring man, and by all accounts he is. That’s certainly how he came across in his remarks earlier this month at the NIH’s meeting on ME/CFS research. But anyone who runs the …
Trial By Error: Jennie Spotila on Collins’ NIH Talk Read More »
